1 May 2019
WideCells Group PLC ('WideCells' or 'the Company)
Corporate Update
WideCells announces that Mr. Peter Presland has stepped down from the Board as a Non-Executive Director with immediate effect in order to pursue his other business interests. Mr. Presland has been a Director since December 2017, and the Board would like to thank him for his contribution and wishes him well in the future.
The Company also announces that following the change in strategy and the arrival of the Iconic Labs team, it has terminated the engagement of Align Research, again with immediate effect.
**ENDS**
For further information, please visit the Company's website www.iconiclabs.co.uk or contact:
Shard Capital Partners LLP |
Joint Broker - Damon Heath & Erik Woolgar |
Tel: +44 (0) 20 7186 9950 |
finnCap Ltd |
Joint Broker - Christopher Raggett |
Tel: +44 (0) 20 7220 0500 |
St Brides Partners Limited |
PR - Melissa Hancock & Juliet Earl |
Tel: +44 (0) 20 7236 1177 |